PharmaTech Integrates 2020 Track 1
Welcome and opening remarks
Revolution not evolution of Biologics production
Stepping up to meet patient need and market demand. Streamlining, enhancing and integrating upstream and downstream biological and vaccine production. Delivering more efficient and flexible production to dynamically address the demand side
LUCY FOLEY | Director of Biologics | CPI
JONATHAN HAIGH | Vice President, Process Development | FUJIFILM Diosynth Biotechnologies
MARK PROCTOR CBE | General Manager R&D and Operations | AstraZeneca
JAMES MISKIN | Chief Technical Officer | Oxford Biomedica
JAMIE UNWIN | Commercial Insight Officer | Nanoform
PAUL DALBY | Co-Director | Future Targeted Healthcare Manufacturing Hub
Digital Twins and MicroFactories
Directors, Prof Alastair Florence and Massimo Bresciani, will present on how CMAC are working on flexible integrated manufacturing technologies to accelerate product and process development, providing greater agility, sustainability and flexibility for future medicines development and manufacture.
The combination of digital design and predictive tools; smart, adaptive workflows and data systems with instrumented MicroFactory platforms and Quality by Digital Design concepts will create new patient centric supply chain solutions and secure access to medicines for patients.
What are the benefits when using the Glatt MODCOS (MODular COntinuous System )?
An introduction and overview on Glatt’s world of continuous manufacturing for OSD-Pharma. Glatt-MODCOS offers a wide range of processing capabilities and options due to the unique modular approach. From as low as 1kg/h up to over 1’000kg/h can be processed with Glatt continuous processing equipment. Direct compression and Wet Granulation. It is not only the equipment – the comprehensive service on process development and process guidance complete the full scope approach. Come in and have a look!
Making solid progress in Continuous Direct Compression
Building smart and dynamic collaborations that increase the adoption of continuous manufacturing principles and practice, with clear data modeling strategies, applied across the spectrum of finished dose forms.
JON-PAUL SHERLOCK | Head of Innovative Manufacturing Technology | AstraZeneca
ALASTAIR FLORENCE | Director, Continuous Manufacturing and Advanced Crystallisation (CMAC) Research Hub | University of Strathclyde
MOHAN GANAPATHY | Head, Global Quality and Compliance | Merck & Company, USA
ANDREAS GOTTSCHALK | Business Development Key Technologies Pharma, MODCOS | Glatt
ALASTAIR COUPE | Senior Director, Drug Product Design, Pharmaceutical Sciences | Pfizer Ltd
FERNANDO MUZZIO | Distinguished Professor of Chemical and Biochemical Engineering | Rutgers University
Getting value from process data in advanced pharma manufacturing
Intelligent measurement, modelling and control are at the heart of Pharma 4.0. Getting the right data and using it properly are crucial for effective digitisation of advanced manufacturing.
The Centre for Process Analytics and Control Technology (CPACT) is the leading “community of practice” in the development and use of advanced process monitoring and control techniques.
The CPACT Showcase will explain the CPACT ethos and illustrate how it supports scientists and engineers working in process analysis, chemometrics and statistics, and process modelling and control through unique cross-sector cooperation. If advances in these PAT areas are important to you and your teams, this Showcase will be of interest to you and your colleagues.
Intense thinking for API manufacture
CLIVE BADMAN OBE | Executive Director | University of Strathclyde
MARK TALFORD | Deputy Challenge Director | Medicines Manufacturing
SALVATORE MASCIA | Founder & Chief Executive Officer | CONTINUUS Pharmaceuticals
RAJEEV BUDHDEV | Executive Vice President & Head – API R&D | Dr. Reddy’s Laboratories
RUTH HARDY | Director Chemical Research | Pfizer
MIKE GIBSON | Chief Technical Officer | Sterling Pharma Solutions